Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Age 70 years or older.~* Patients with hypertension prior to being randomized into study.~* Patients must have an office cuff MSSBP ≥ 140 and ≤ 200 mmHg systolic.~* Have the ability to communicate and comply with all study requirements.~* Provide written informed consent to participate in the study prior to any screening or study procedures.~Exclusion Criteria:~* Use of other investigational drugs within 30 days of enrollment.~* History of hypersensitivity to any of the study drugs or to drugs of similar chemical classes.~* Office blood pressure measured by office machine cuff with a mean of (3) MSDBP ≥ 120 mmHg at anytime during the screening / washout period.~* Patients taking 3 or more antihypertensive drugs and MSSBP ≥ 160 mmHg at the time of Visit 1.~* Other protocol-defined exclusion criteria may apply

- Gender: ALL
- Minimum Age: 70 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Valsartan (Type: ACTIVE_COMPARATOR): (patients initiated on valsartan)
- HCTZ (Type: ACTIVE_COMPARATOR): (patients initiated on HCTZ)
- Valsartan + HCTZ (Type: EXPERIMENTAL): (patients initiated on Valsartan+HCTZ)

Based on this trial design, predict the completion outcome and termination type (if applicable).